Literature DB >> 11989789

Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.

Elzbieta Kolaczkowska1, Susan Shahzidi, Rolf Seljelid, Nico van Rooijen, Barbara Plytycz.   

Abstract

The initial phase of zymosan-induced peritonitis involves an increase of vascular permeability (peak at 30 min) that is correlated with high levels of vasoactive eicosanoids, namely, prostaglandins (PGI2 and PGE2) of cyclooxygenase-1 origin (as estimated by RT-PCR) and cysteinyl-leukotrienes. Previously, we showed that the increase of vascular permeability can be attributed only partially to mast cells and their histamine, as seen in mast cell-deficient WBB6F1-W/Wv mice. Thus we aimed to identify the major cellular source(s) that mediate vasopermeability, as well as particular vasoactive mediators operating in this model. For this purpose, some mice were selectively depleted of either peritoneal macrophages or mast cells, and/or they were treated with several pharmacologic inhibitors of cyclooxygenase- and lipoxygenase-metabolic pathways. More-over, macrophage-depleted mast cell-deficient WBB6F1-W/Wv mice and their controls (+/+) were used. The macrophage depletion always caused a profound decrease of both vascular permeability and lipid-mediator levels, which was particularly pronounced for leukotrienes, whereas the effects of mast-cell depletion were less severe. The macrophage/mast-cell co-mediation of vasopermeability was also revealed in thioglycolate-induced peritonitis, as well as the macrophage origin of cysteinyl-leukotrienes. Taken together, these findings demonstrate that the resident peritoneal macrophages are in fact the main contributors to the vasopermeability at the early stages of zymosan-induced peritonitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11989789     DOI: 10.1023/a:1014837110735

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  58 in total

Review 1.  Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature.

Authors:  P Hedqvist; N Gautam; L Lindbom
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation.

Authors:  I Posadas; M C Terencio; I Guillén; M L Ferrándiz; J Coloma; M Payá; M J Alcaraz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-01       Impact factor: 3.000

Review 3.  Mast cells and basophils in innate immunity.

Authors:  S N Abraham; M Arock
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

Review 4.  The role of histamine and other mediators in microvascular changes in acute inflammation.

Authors:  H Z Movat
Journal:  Can J Physiol Pharmacol       Date:  1987-03       Impact factor: 2.273

Review 5.  The kinin system in inflammation.

Authors:  J M Stewart
Journal:  Agents Actions Suppl       Date:  1993

6.  Murine alpha-2-macroglobulin increase during inflammatory responses and tumor growth.

Authors:  L Isaac; M P Florido; D Fecchio; L M Singer
Journal:  Inflamm Res       Date:  1999-08       Impact factor: 4.575

7.  Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action.

Authors:  A M Das; R J Flower; M Perretti
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

8.  Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo.

Authors:  N Futaki; S Takahashi; T Kitagawa; Y Yamakawa; M Tanaka; S Higuchi
Journal:  Inflamm Res       Date:  1997-12       Impact factor: 4.575

9.  Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells.

Authors:  H Bult; M C Coene; M Rampart; A G Herman
Journal:  Agents Actions Suppl       Date:  1984

10.  Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

Authors:  D M Humphrey; L M McManus; D J Hanahan; R N Pinckard
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

View more
  11 in total

1.  N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever.

Authors:  Ana Paula Oliveira Ferreira; Juliana Saibt Martins Pasin; André Luis Lopes Saraiva; Viviane Ratzlaff; Mateus Fortes Rossato; Rosália Andrighetto; Maribel Antonello Rubin; Juliano Ferreira; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2011-11-08       Impact factor: 4.575

2.  2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Lipids       Date:  2011-07-10       Impact factor: 1.880

3.  Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle.

Authors:  J Pablo Abonia; Daniel S Friend; William G Austen; Francis D Moore; Michael C Carroll; Rodney Chan; Jalil Afnan; Alison Humbles; Craig Gerard; Pamela Knight; Yoshihide Kanaoka; Shinsuke Yasuda; Nasa Morokawa; K Frank Austen; Richard L Stevens; Michael F Gurish
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

4.  Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

5.  Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory.

Authors:  Long Shuang Huang; Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Lipids       Date:  2010-02-18       Impact factor: 1.880

6.  Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Authors:  Elzbieta Kolaczkowska; Barbara Plytycz; Bernd Arnold; Helene Piccard; Ghislain Opdenakker
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

7.  Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.

Authors:  Salvatore Cuzzocrea; Antonietta Rossi; Ivana Serraino; Rosanna Di Paola; Laura Dugo; Tiziana Genovese; Domenico Britti; Giuseppe Sciarra; Angelina De Sarro; Achille P Caputi; Lidia Sautebin
Journal:  Intensive Care Med       Date:  2004-07-06       Impact factor: 17.440

8.  Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation.

Authors:  Simona Zarini; Miguel A Gijón; Aaron E Ransome; Robert C Murphy; Angelo Sala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

9.  The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).

Authors:  C Pergola; J Gerstmeier; B Mönch; B Çalışkan; S Luderer; C Weinigel; D Barz; J Maczewsky; S Pace; A Rossi; L Sautebin; E Banoglu; O Werz
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand.

Authors:  Tomoko Hayashi; Shiyin Yao; Brian Crain; Michael Chan; Howard B Cottam; Fitzgerald Lao; Dennis A Carson; Maripat Corr
Journal:  Mediators Inflamm       Date:  2011-11-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.